Liposomal glutathione: A breakthrough in cellular health by West Bengal chemical industries Ltd., Ko

Citation: Poulami Gupta Banerjee, Atanuka Paul, Argha Chakraborty, Subrata Kundu. Liposomal glutathione: A breakthrough in cellular health by West Bengal chemical industries Ltd., Kolkata, India. Pharma Innovation 2025;14(2):73-81. https://www.thepharmajournal.com/archives/?year=2025&vol=14&issue=2&ArticleId=26022

Abstract: Liposomal Glutathione, manufactured by West Bengal Chemical Industries Ltd. (WBCIL), represents a cutting-edge advancement in nutraceutical technology, designed to optimize the bioavailability and therapeutic potential of glutathione. As a potent antioxidant, glutathione plays a critical role in cellular detoxification, immune support, and the prevention of oxidative damage associated with aging, chronic diseases, and environmental stressors. Traditional oral glutathione supplements often face challenges in bioavailability due to degradation in the digestive tract, limiting their effectiveness. In contrast, liposomal encapsulation enhances glutathione's stability, absorption, and targeted delivery to specific tissues, overcoming these limitations. This study explores the key benefits of WBCIL’s Liposomal Glutathione, comparing it to conventional formulations and providing a comprehensive review of scientific evidence supporting its superior efficacy. The data highlights the potential of liposomal glutathione in improving systemic glutathione levels, reducing oxidative stress, supporting immune function, and promoting cardiovascular and neuroprotective health. Results from assay analysis, encapsulation efficiency, and FTIR spectroscopy further confirm the enhanced stability and bioavailability of the product. WBCIL’s Liposomal Glutathione offers a promising solution for individuals seeking to boost their antioxidant levels, improve cellular health, and mitigate the risks of chronic conditions associated with oxidative stress.